CN101466355A - 具有抗细菌、抗真菌、抗酵母和/或抗病毒性质的纳米化组合物 - Google Patents

具有抗细菌、抗真菌、抗酵母和/或抗病毒性质的纳米化组合物 Download PDF

Info

Publication number
CN101466355A
CN101466355A CNA2007800213152A CN200780021315A CN101466355A CN 101466355 A CN101466355 A CN 101466355A CN A2007800213152 A CNA2007800213152 A CN A2007800213152A CN 200780021315 A CN200780021315 A CN 200780021315A CN 101466355 A CN101466355 A CN 101466355A
Authority
CN
China
Prior art keywords
less
oil
activating agent
compositions
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800213152A
Other languages
English (en)
Chinese (zh)
Inventor
迪尼什·施诺伊
罗伯特·李
克雷格·赖特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novavax Inc
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novavax Inc filed Critical Novavax Inc
Publication of CN101466355A publication Critical patent/CN101466355A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA2007800213152A 2006-04-07 2007-04-03 具有抗细菌、抗真菌、抗酵母和/或抗病毒性质的纳米化组合物 Pending CN101466355A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78991706P 2006-04-07 2006-04-07
US60/789,917 2006-04-07

Publications (1)

Publication Number Publication Date
CN101466355A true CN101466355A (zh) 2009-06-24

Family

ID=38436994

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800213152A Pending CN101466355A (zh) 2006-04-07 2007-04-03 具有抗细菌、抗真菌、抗酵母和/或抗病毒性质的纳米化组合物

Country Status (6)

Country Link
EP (1) EP2010149A1 (fr)
JP (1) JP2009533341A (fr)
CN (1) CN101466355A (fr)
AU (1) AU2007240983A1 (fr)
CA (1) CA2648360A1 (fr)
WO (1) WO2007123790A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104884074A (zh) * 2012-10-26 2015-09-02 Isp投资公司 源自亚麻蛋白质水解的亚麻提取物作为活性抗微生物剂的用途
CN105241793A (zh) * 2015-09-07 2016-01-13 国家纳米科学中心 一种载药胶束形态粒径的测定方法

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2618974C (fr) 2005-08-09 2014-01-28 Nanobio Corporation Compositions de nanoemulsions possedant une activite anti-inflammatoire
US20080139513A1 (en) * 2006-09-26 2008-06-12 Novavax, Inc. Transdermal deliver of active agents
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
US9687429B2 (en) 2007-06-20 2017-06-27 The Trustees Of Columbia University In The City Of New York Antimicrobial compositions containing low concentrations of botanicals
EP2166840B1 (fr) 2007-06-20 2017-01-11 The Trustees of Columbia University in the City of New York Surfaces résistantes à la formation de biofilm
CN101959429B (zh) * 2008-01-08 2014-09-10 阿克塞利亚制药公司 抗微生物肽系统的激动剂
EP2448416A4 (fr) * 2009-06-30 2013-03-20 Univ Columbia Compositions antimicrobiennes/de conservation comprenant des agents botaniques
DK2773334T3 (da) 2011-11-03 2019-12-09 Univ Columbia Sammensætning med forlænget antimikrobiel aktivitet
US9968101B2 (en) 2011-11-03 2018-05-15 The Trustees Of Columbia University In The City Of New York Botanical antimicrobial compositions
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
WO2013086094A1 (fr) 2011-12-06 2013-06-13 The Trustees Of Columbia University In The City Of New York Composition d'agent de conservation naturelle à large spectre
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
KR20150110554A (ko) 2013-01-25 2015-10-02 케미라 오와이제이 살생물제 조성물 및 수처리 방법
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
EP3174542A4 (fr) 2014-07-29 2018-01-03 TherapeuticsMD, Inc. Crème transdermique
WO2017002117A1 (fr) * 2015-07-01 2017-01-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Systèmes d'administration pour le propofol
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN106551902B (zh) * 2015-09-17 2020-07-03 阿赖耶识（上海）生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
EP3332787A4 (fr) * 2015-09-30 2018-08-01 Fujifilm Corporation Composition absorbable par voie transdermique
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CN113728865B (zh) * 2021-09-24 2022-12-13 广西壮族自治区亚热带作物研究所（广西亚热带农产品加工研究所） 一种澳洲坚果促花保果的综合管理方法
BE1030538B1 (nl) * 2022-05-18 2023-12-19 Bogaert Gina Van Liposomaal preparaat met ingekapselde hormonen, werkwijze voor de productie en gebruik ervan
AU2024336286A1 (en) * 2023-09-06 2026-03-12 The Board Of Regents Of The University Of Texas System Compositions and methods of ent-testosterone for treatment of bacterial infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629021A (en) * 1995-01-31 1997-05-13 Novavax, Inc. Micellar nanoparticles
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
CA2528095C (fr) * 2003-06-04 2014-10-14 Nanobio Corporation Compositions pour l'inactivation de micro-organismes pathogenes, procedes de fabrication de compositions, et leurs procedes d'utilisation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104884074A (zh) * 2012-10-26 2015-09-02 Isp投资公司 源自亚麻蛋白质水解的亚麻提取物作为活性抗微生物剂的用途
CN104884074B (zh) * 2012-10-26 2019-08-20 Isp投资公司 源自亚麻蛋白质水解的亚麻提取物作为活性抗微生物剂的用途
CN105241793A (zh) * 2015-09-07 2016-01-13 国家纳米科学中心 一种载药胶束形态粒径的测定方法

Also Published As

Publication number Publication date
EP2010149A1 (fr) 2009-01-07
CA2648360A1 (fr) 2007-11-01
AU2007240983A1 (en) 2007-11-01
WO2007123790A1 (fr) 2007-11-01
JP2009533341A (ja) 2009-09-17

Similar Documents

Publication Publication Date Title
EP2010149A1 (fr) Compositions nanostructures aux proprietes antibacteriennes, antifongiques, anti-levures et/ou antivirales
Garcia et al. Nanoemulsion delivery systems for enhanced efficacy of antimicrobials and essential oils
Håkansson et al. Characterization of the in vitro, ex vivo, and in vivo efficacy of the antimicrobial peptide DPK-060 used for topical treatment
Pavoni et al. Microemulsions: An effective encapsulation tool to enhance the antimicrobial activity of selected EOs
CN101848702B (zh) 两亲实体纳米粒子
EP1993515B1 (fr) Procédé pour solubiliser, disperser et stabiliser des matières, produits réalisés par ce procédé et leur utilisation
DE69213010T2 (de) Verwendung eines Bakteriozin antibiotischen Agenten zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden.
US20070264349A1 (en) Nano-structured compositions and methods of making and using the same
EP2633862B1 (fr) Compositions à base de nanocapsules de propolis utilisables comme supports de substances d'intérêt, procédé d'obtention et utilisation
CA2722445A1 (fr) Nanoemulsions destinees a traiter des infections fongiques, et des infections provoquees par de la levure et de la moisissure
JP2005514325A (ja) 抗微生物ナノエマルジョンの組成物および方法
US20040043041A1 (en) Antimicrobial compositions and methods of use
Hashempur et al. Topical Delivery Systems for Plant‐Derived Antimicrobial Agents: A Review of Current Advances
Shahid et al. Antifungal cationic nanoemulsion ferrying miconazole nitrate with synergism to control fungal infections: in vitro, ex vivo, and in vivo evaluations
Aremu et al. Antibacterial evaluation of Acacia nilotica Lam (Mimosaceae) seed extract in dermatological preparations
CN101516358A (zh) 抗病毒组合物以及它们的使用
JP5811421B2 (ja) 保存効力を示す非水性油性注射用製剤
Zhang et al. Preparation and characterization of natural quercetin-based Mongolia Medicine SenDeng-4 nanoemulsion (N-QUE-NE) and its antibacterial activity
JP7700987B2 (ja) 脂質封入両親媒性ペプチド
Ishaq et al. Development and in vitro evaluation of cost effective amphotericin B polymeric emulsion
Buldain et al. Antimicrobial activity of nanostructured lipid carriers loaded with Melaleuca armillaris essential oil against Staphylococcus aureus sensitive and resistant to methicillin
CN104083324B (zh) 一种利福昔明的兽用悬乳剂及其制备方法和应用
WO2021030250A1 (fr) Procédés pour augmenter la biodisponibilité de médicaments pharmaceutiques et sans ordonnance ("otc")
CN102920656A (zh) 一种莫西沙星纳米乳及其制备方法
CN115671040A (zh) 一种控制动物寄生虫感染的外用制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090624